Zika Virus-Associated Cerebellitis with Complete Clinical Recovery
Zika virus (ZIKV) was first detected in the Americas in Brazil in 2015, with a rapid spread to surrounding countries. In Panama, the outbreak began in November 2015 in an indigenous community located on the Caribbean side of the country. Zika virus is typically associated with a diffuse rash, fever,...
Saved in:
Published in | The American journal of tropical medicine and hygiene Vol. 99; no. 5; pp. 1318 - 1320 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Institute of Tropical Medicine
01.01.2018
The American Society of Tropical Medicine and Hygiene |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Zika virus (ZIKV) was first detected in the Americas in Brazil in 2015, with a rapid spread to surrounding countries. In Panama, the outbreak began in November 2015 in an indigenous community located on the Caribbean side of the country. Zika virus is typically associated with a diffuse rash, fever, and conjunctivitis. It can rarely cause neurologic manifestations, most commonly microcephaly and Guillain-Barré syndrome. Encephalitis and acute encephalomyelitis are known complications, but ZIKV-associated cerebellitis has yet to be reported in the literature. Herein, we report a case of cerebellitis in a patient infected with ZIKV. This patient developed severe frontal headache and vertigo on the third day of illness, and dysarthria and ataxia on the fifth day. After 1 week of hospitalization, the patient completely recovered. The laboratory serological diagnosis was complicated because of the detection of antibodies against dengue, suggesting a secondary flavivirus infection. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 These authors contributed equally to this work. Authors’ addresses: Mónica R. Pachar, Marixcel Suárez, and Ana B. Araúz, Hospital Santo Tomas, Infectious Diseases, Panama City, Panama, E-mails: dra.pachar@hotmail.com, marixcel@gmail.com, and anabelenarauz@gmail.com. Dimelza Araúz, Brechla Moreno, and Sandra López-Vergès, Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama, E-mails: darauz@gorgas.gob.pa, brechla@yahoo.es, and slopez@gorgas.gob.pa. José Antonio Suarez, Clinical Research Unit, Gorgas Memorial Institute of Health Studies, Panama City, Panama, E-mail: jsuarez@gorgas.gob.pa. Nathan D. Gundacker, Infectious Diseases, UAB Hospital, Birmingham, AL, E-mail: ndgundacker@gmail.com. Financial support: This work has been carried out with management funds of HST and ICGES, as well as MEF. project 09044.051 (S. L. V.). |
ISSN: | 0002-9637 1476-1645 |
DOI: | 10.4269/ajtmh.18-0261 |